Upgrade to SI Premium - Free Trial

CEO Departure Likely to Pressure Alnylam (ALNY) Stock, M&A Possibility Will Likely Fade - Analyst

October 28, 2021 8:41 AM
Earlier today, alongside its Q3 report, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) announced the planned CEO transition of John Maraganore, Ph.D ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Corporate News FDA Management Changes Momentum Movers Trader Talk

Next Articles